What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 2 minute read Pharma Industry News Exonics Therapeutics receives $5m seed funding to advance Duchenne Muscular Dystrophy therapy Exonics Therapeutics, a biotechnology firm based in Boston, Massachusetts, has secured $5 million in seed funding from CureDuchenne… bypharmanewsdailyFebruary 28, 2017